Stocks and InvestingStocks and Investing
Fri, February 10, 2023
Thu, February 9, 2023

Joseph Pantginis Reiterated (VKTX) at Strong Buy and Held Target at $21 on, Feb 9th, 2023


Published on 2024-10-28 01:30:00 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Viking Therapeutics, Inc." (VKTX) at Strong Buy and Held Target at $21 on, Feb 9th, 2023.

Joseph has made no other calls on VKTX in the last 4 months.



There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Naz Rahman of "Maxim Group" Maintained at Strong Buy with Increased Target to $15 on, Tuesday, December 20th, 2022